Peripheral administration of human recombinant ApoJ/clusterin modulates brain beta-amyloid levels in APP23 mice.

Alzheimers Res Ther · 2019 · PMC6511153 · PMID 31077261

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

not yet significantno p-value reported

To confirm this hypothesis, we treated APP23 mice with rApoJ at the time that mouse ApoJ levels elevation was not yet significant.

also in 316 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.